Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain

Biochemical and Biophysical Research Communications

Volumn 366, Issue 1, 2008, Pages 86-91

  Anagli, John ^a   Abounit, Kadija ^a   Stemmer, Paul ^b   Han, Yuxia ^a   Allred, Lisa ^a   Weinsheimer, Shantel ^a   Movsisyan, Ashkhen ^a   Seyfried, Donald ^a  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Albumin; Cathepsin B; Middle cerebral artery occlusion; Neuroprotection; Protease inhibitor; Rat

Indexed keywords

ALBUMIN; CATHEPSIN B; CATHEPSIN L; COLLAPSING MEDIATOR RESPONSE PROTEIN 2; CYSTEINE PROTEINASE INHIBITOR; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 60; PROTEIN; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN REGION; CONTROLLED STUDY; HEMISPHERE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; RAT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN ISCHEMIA; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; HEAT-SHOCK PROTEINS; MALE; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 37549031387     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.104     Document Type: Article

References (36)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., and Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367 (2006) 1747-1757
2. WHO. The World Health Report 2003. Online at http://www.who.int/whr/2003/en/Facts_and_Figures-en.pdf, 2003.
3. Rosamond W., Flegal K., Friday G., et al. Circulation 115 (2007) e99-e110
4. Siesjo B. Calcium and ischemic brain damage. Eur. Neurol. 25 (1986) 45-56
5. Ogata N., Yanekawa Y., Taki W., Kannagi R., Murachi T., Hamakubo T., and Kikuchi H. Degradation of neurofilament protein in cerebral ischemia. J. Neurosurg. 70 (1989) 103-107
6. Yamashima T. Implication of cysteine proteases calpain, cathepsin, and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62 (2000) 273-295
7. Yoshida M., Yamashima T., Zhao L., Tsuchiya K., Kohda Y., Tonchev A., Matsuda M., and Kominami E. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathol. (2002) 1-15
8. Yamashima T., Kohda Y., Tsuchiya K., Ueno T., Yamashita J., Yoshioka T., and Kominami E. Inhibition of ischemic hippocampal neuronal cell death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci 10 (1998) 1723-1733
9. Kohda Y., Yamashima T., Sahuha K., Yamashita J., Vmo T., Kominami E., and Yoshioka T. Dynamic changes of cathepsins B and L expression in monkey hippocampus after transient ischemia. Biophys. Res. Commun. 228 (1996) 616-622
10. Hill I., Preston E., Monette R., and MacManus J. A comparison of cathepsin processing and distribution during neuronal death in rats following global ischemia or decapitation necrosis. Brain Res. 751 (1997) 206-216
11. Seyfried D., Han Y., Zheng Z., Day N., Moin K., Rempel S., and Sloane B. Cathepsin B and middle cerebral artery occlusion in the rat. J. Neurosurg. 87 (1997) 716-723
12. Seyfried D.M., Veyna R., Han Y., Li K., Tang N., Betts R.S., Weinsheimer S., Chopp M., and Anagli J. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia. Brain Res. 901 (2001) 94-101
13. Benchoua A., Braudeau J., Reis A., Couriaud C., and Onteniente B. Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 24 (2004) 1272-1279
14. Shaw E., Wikstrom P., and Ruscica J. An exploration of the primary specificity site of cathepsin B. Arch. Biochem. Biophys. 222 (1983) 424-429
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
16. Towbin H., Staehelin T., and Gordon J. Electrophorectic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 4350-4354
17. Chen A., Liao W.O., Lu Q., Wong W., and Wong P.T. Upregulation of dihydropyrimidin ase related protein 2, spectrin a II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats- a proteomics approach. Neurochem. Intl. 50 (2007) 1078-1086
18. Ko H.S., Uehara T., and Nomura Y. Role of ubiquilin associated with protein-disulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death. J. Biol. Chem. 277 (2002) 35386-35392
19. Rajdev S., Hara K., Kokubo Y., Mestrill R., Dillmann W., Weinstein P.R., and Sharp F.R. Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann. Neurol. 47 (2000) 782-791
20. Ahn S.G., Kim S.A., Yoon J.H., and Vacratsis P. Heat-shock cognate 70 is required for the activation of heat-shock factor 1 in mammalian cells. Biochem. J. 392 (2005) 145-152
21. Hwang I.K., Ahn H.C., Yoo K.-Y., Lee J.-Y., Suh H.-W., Kwon Y.-G., Cho J.H., and Won M.-H. Changes in immunoreactivity of HSP60 and its neuroprotective effects in the gerbil hippocampal CA1 region induced by transient ischemia. Exp. Neurol. (2007) 10.1016/j.expneurol.2007.08.017
22. Chung M.A., Lee J.E., Lee J.Y., Ko M.J., Lee S.T., and Kim H.J. Alteration of collapsing response mediator protein-2 expression in focal ischemic rat brain. Neuroreport 16 (2005) 1647-1653
23. Shirvan A., Ziv I., Fleminger G., Shina R., He Z., Brudo I., Melamed E., and Barzilai A. Semaphorins as mediators of neuronal apoptosis. J. Neurochem. 73 (1999) 961-971
24. Bretin S., Rogemond V., Marin P., Maus M., Torrens Y., Honnnorat J., Glowinski J., Premont J., and Gauchy C. Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J. Neurochem. 98 (2006) 1252-1265
25. Jiang S.X., Kappler J., Zurakowski B., Desbois A., Aylsworth A., and Hou S. Calpain cleavage of collapsin response mediator proteins in ischemic mouse brain. Eur. J. Neurosci. (2007) 1-9
26. Zipser B.D., Johanson C.E., Gonzalez L., Berzin T.M., Tavares R., Hulette C.M., Vitek M.P., Hovanesian V., and Stopa E.G. Microvascular injury and blood-brain-barrier leakage in Alzheimer's disease. Neurobiol. Aging 28 (2007) 977-986
27. Lu A., Yu H., Chen K., Koide S.S., and Li X. Alteration in brain proteins following occlusion of the middle cerebral artery in rat. Life Sci. 65 (1999) 493-500
28. Fukuda S., Fini C.A., Mabuchi T., Koziol J.A., Eggleston L.L., and del Zoppo G.J. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35 (2004) 998-1004
29. Hampel H., Muller-Spahn F., Berger C., Haberl A., Ackenheil M., and Hock C. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients of the Alzheimer type and major depression: a possible indicator for immunoactivation. Dementia 6 (1995) 348-354
30. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., and Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatr. 5 (2000) 142-149
31. Schonberger S.J., Edgar P.F., Kydd R., Faull R.L., and Cooper G.J. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 1 (2001) 1159-1528
32. Zabel C., Chamrad D.C., Priller J., Woodman B., Meyer H.E., Bates G.P., and Klose J. Alterations in the mouse and human proteome caused by Huntington's disease. Mol. Cell. Proteomics 1 (2002) 366-375
33. Engidawork E., Gulesserian T., Fountoulakis M., and Lubec G. Aberrant protein expression in cerebral cortex of fetus with Down syndrome. Neuroscience 122 (2003) 145-154
34. Carrette O., Burgess J.A., Burkhard P.R., Lang C., Cote M., Rodrigo N., Hochstrasser D.F., and Sanchez J.C. Changes of the cortex proteome and Apolipoprotein E in transgenic mouse models of Alzheimer's disease. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 840 (2006) 1-9
35. Kobeissy F.H., Ottens A.K., Zhang Z., Liu M.C., Denslow N.D., Dave J.R., Tortella F.C., Hayes R.L., and Wang K.K. Novel differential neuroproteomic analysis of traumatic brain injury in rats. Mol. Cell. Proteomics 5 (2006) 1887-1898
36. Maurer M.H., Berger C., Wolf M., Futterer C.D., Feldmann Jr. R.E., Schwab S., and Kuschinsky W. The proteome of human brain microdialysate. Proteome Sci. 1 (2003) 7